126 related articles for article (PubMed ID: 11327217)
1. Methotrexate poisoning with acute hepatorenal dysfunction.
Goto E; Tomojiri S; Okamoto I; Tanaka K
J Toxicol Clin Toxicol; 2001; 39(1):101-4. PubMed ID: 11327217
[TBL] [Abstract][Full Text] [Related]
2. Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase.
Vilay AM; Mueller BA; Haines H; Alten JA; Askenazi DJ
Pharmacotherapy; 2010 Jan; 30(1):111. PubMed ID: 20030480
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of hemodialysis in a case of acute methotrexate poisoning].
Gauthier E; Gimonet JF; Piedbois P; Rostoker G; Buisson C; Ben Maadi A; Samyn B; Messadi AA; Brun B; Feuilhade F
Presse Med; 1990 Dec 22-29; 19(44):2023-5. PubMed ID: 2148614
[TBL] [Abstract][Full Text] [Related]
4. Effect of charcoal hemoperfusion for removal of plasma methotrexate in a patient with acute renal failure.
Nemoto T; Imai C; Kaneko U; Takachi T; Iwabuchi H; Tanaka A; Nakamura G; Ogose A; Uchiyama M
Pediatr Hematol Oncol; 2009; 26(7):520-5. PubMed ID: 19863208
[TBL] [Abstract][Full Text] [Related]
5. Difficulty measuring methotrexate in a patient with high-dose methotrexate-induced nephrotoxicity.
Al-Turkmani MR; Law T; Narla A; Kellogg MD
Clin Chem; 2010 Dec; 56(12):1792-4. PubMed ID: 21119035
[No Abstract] [Full Text] [Related]
6. The utility of online haemodiafiltration in methotrexate poisoning.
Abdelsalam MS; Althaf MM; Alfurayh O; Maghfoor I
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24859553
[TBL] [Abstract][Full Text] [Related]
7. Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation.
Estève MA; Devictor-Pierre B; Galy G; André N; Coze C; Lacarelle B; Bernard JL; Monjanel-Mouterde S
Eur J Clin Pharmacol; 2007 Jan; 63(1):39-42. PubMed ID: 17115148
[No Abstract] [Full Text] [Related]
8. High-dose leucovorin as sole therapy for methotrexate toxicity.
Flombaum CD; Meyers PA
J Clin Oncol; 1999 May; 17(5):1589-94. PubMed ID: 10334548
[TBL] [Abstract][Full Text] [Related]
9. Commentary.
Milone MC
Clin Chem; 2010 Dec; 56(12):1795-6. PubMed ID: 21119036
[No Abstract] [Full Text] [Related]
10. Commentary.
Fox E; Balis FM
Clin Chem; 2010 Dec; 56(12):1795. PubMed ID: 21119037
[No Abstract] [Full Text] [Related]
11. Continuous veno-venous hemodiafiltration in methotrexate intoxication.
Ziółkowska H; Kisiel A; Leszczyńska B; Bilska K; Jankowska K; Kuźma-Mroczkowska E; Stelmaszczyk-Emmel A; Woźniak W; Roszkowska-Blaim M
Med Wieku Rozwoj; 2013; 17(4):347-54. PubMed ID: 24519778
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy.
Widemann BC; Schwartz S; Jayaprakash N; Christensen R; Pui CH; Chauhan N; Daugherty C; King TR; Rush JE; Howard SC
Pharmacotherapy; 2014 May; 34(5):427-39. PubMed ID: 24132809
[TBL] [Abstract][Full Text] [Related]
13. [Carboxypeptidase-G2 rescue of methotrexate intoxication].
Grill J; Amigo-Ferreiro ME; Schoepfer C; Bonnay M; Valteau-Couanet D; Hartmann O; Vassal G
Bull Cancer; 1998 Dec; 85(12):1066. PubMed ID: 9917559
[No Abstract] [Full Text] [Related]
14. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC
Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136
[TBL] [Abstract][Full Text] [Related]
15. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
Nowicki TS; Bjornard K; Kudlowitz D; Sandoval C; Jayabose S
J Pediatr Hematol Oncol; 2008 Dec; 30(12):950-2. PubMed ID: 19131789
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interaction between high-dose methotrexate and oxacillin.
Titier K; Lagrange F; Péhourcq F; Moore N; Molimard M
Ther Drug Monit; 2002 Aug; 24(4):570-2. PubMed ID: 12142645
[TBL] [Abstract][Full Text] [Related]
17. Optimal management of methotrexate intoxication in a child with osteosarcoma.
Peyriere H; Cociglio M; Margueritte G; Vallat C; Blayac JP; Hillaire-Buys D
Ann Pharmacother; 2004 Mar; 38(3):422-7. PubMed ID: 14970366
[TBL] [Abstract][Full Text] [Related]
18. Continuous plasma resin perfusion for detoxification of methotrexate.
Greil J; Wyss PA; Ludwig K; Bonakdar S; Scharf J; Beck JD; Ruder H
Eur J Pediatr; 1997 Jul; 156(7):533-6. PubMed ID: 9243235
[TBL] [Abstract][Full Text] [Related]
19. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
[TBL] [Abstract][Full Text] [Related]
20. Association of plasma methotrexate, neutropenia, hepatic dysfunction, nausea/vomiting and oral mucositis in children with cancer.
Cheng KK
Eur J Cancer Care (Engl); 2008 May; 17(3):306-11. PubMed ID: 18419635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]